 |
Supersonic ImagineIUS 2016: Booth N° 20 |
Founded in 2005 and based in Aix-en-Provence, France, SuperSonic Imagine is an innovative, multinational medical imaging company dedicated to developing a revolutionary ultrasound system: the Aixplorer®. Aixplorer relies on a patented software platform that acquires information at up to 20,000 images per second (200 times faster than conventional ultrasound). This system leverages a unique MultiWave™ technology that enables the user to detect, characterize and, in the future, treat palpable and non-palpable masses.
MultiWave technology is based on combining two types of waves: an ultrasound wave that provides exceptional imaging in B-mode, and a shear wave, ShearWave™ Elastography, which measures and displays the stiffness of tissue in kilopascals. ShearWave Elastography is user-skill independent with reproducible results.
Angio PL.U.S. – PlaneWave UltraSensitive™ ultrasound imaging – provides a new level of microvascular imaging through significantly improved color sensitivity and spatial resolution while maintaining exceptional 2D imaging. Angio PL.U.S. leverages the combination of ultrafast imaging and 3D wall filtering to create a leap in ultrasound doppler imaging performance. Thanks to its ability to detect microvascularization in different types of lesions this new mode could open the door to added clinical information and diagnostic perspectives, in both benign and malignant lesions in areas such as the breast, liver, lymph nodes and thyroid as well as musculoskeletal pathologies.
SuperSonic Imagine has both a direct sales and distribution network in more than 50 countries worldwide, including Konica Minolta in Japan. SuperSonic Imagine holds the exclusive right, title and interest to 30 international patents and submissions in diagnostic imaging and therapy applications. Company investors include Edmond de Rothschild Investment Partners (EdRIP), Auriga Partners, Crédit Agricole Private Equity (CAPE), NBGI Ventures, Bioam, Mérieux Développement, Wellington Partners, Innobio, Canon (NYSE:CAJ), and IXO Private Equity.
Onsite contact:
Jeremy Bercoff
Email: Jeremy.Bercoff (@) supersonicimagine.com
 |
||
 |
 |
|